ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,297.10
-0.21%
US Tech 100
18,069.60
-0.05%
다우존스 지수
39,869.38
-0.10%
Bitcoin
66,292.45
1.61%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Takeda Pharmaceutical Co Ltd (0RN3)

  7. Takeda Pharmaceutical Co Ltd (0RN3) 뉴스

0RN3

Takeda Pharmaceutical (0RN3)

Takeda Pharmaceutical Co Ltd
일자:
정렬 기준:
 검색 관련기사 보기:LSE:0RN3
일자시간출처헤드라인심볼기업
2024/05/0917:36Alliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical profit sinks as expenses mountLSE:0RN3Takeda Pharmaceutical Co Ltd
2024/04/2304:41Alliance NewsAlliance NewsTakeda, Astellas and Sumitomo to create new drug discovery companyLSE:0RN3Takeda Pharmaceutical Co Ltd
2024/03/2721:56PR Newswire (US)Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAELSE:0RN3Takeda Pharmaceutical Co Ltd
2024/03/2721:53PR Newswire (US)Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAELSE:0RN3Takeda Pharmaceutical Co Ltd
2023/11/0921:16Alliance NewsAlliance NewsHutchmed hails Takeda's fruquintinib approval from US for cancer formLSE:0RN3Takeda Pharmaceutical Co Ltd
2023/10/3021:24Alliance NewsAlliance NewsTakeda Pharmaceutical first half profit falls as costs outpace revenueLSE:0RN3Takeda Pharmaceutical Co Ltd
2023/09/2918:12Alliance NewsAlliance NewsHutchmed notes Takeda submits fruquintinib drug application in JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
2023/09/2223:15PR Newswire (US)Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and OlderLSE:0RN3Takeda Pharmaceutical Co Ltd
2023/07/2718:26Alliance NewsAlliance NewsTakeda keeps guidance unchanged despite drop in quarterly profitLSE:0RN3Takeda Pharmaceutical Co Ltd
2023/07/1221:22Alliance NewsAlliance NewsJapan's Takeda pulls dengue vaccine candidate in USLSE:0RN3Takeda Pharmaceutical Co Ltd
2023/07/1213:16Alliance NewsAlliance NewsJapan's Takeda pulls dengue vaccine candidate in USLSE:0RN3Takeda Pharmaceutical Co Ltd
2023/06/1616:51Alliance NewsAlliance NewsHutchmed, Takeda Fresco-2 study published in The LancetLSE:0RN3Takeda Pharmaceutical Co Ltd
2023/05/1119:51Alliance NewsAlliance NewsTOP NEWS: Takeda outlook downbeat as Covid wanes, hit from genericsLSE:0RN3Takeda Pharmaceutical Co Ltd
2023/02/0219:57Alliance NewsAlliance NewsTakeda Pharmaceutical set for annual guidance as 9-month results upLSE:0RN3Takeda Pharmaceutical Co Ltd
2022/12/0901:49Alliance NewsAlliance NewsTakeda Pharmaceutical gets EC approval for dengue vaccineLSE:0RN3Takeda Pharmaceutical Co Ltd
2022/11/2321:49Alliance NewsAlliance NewsIN BRIEF: USD FDA accepts Takeda's TAK-003 for priority reviewLSE:0RN3Takeda Pharmaceutical Co Ltd
2022/07/2901:10Alliance NewsAlliance NewsTakeda first quarter profit drops despite revenue increaseLSE:0RN3Takeda Pharmaceutical Co Ltd
2022/05/1121:23Alliance NewsAlliance NewsTakeda annual profit drops on investment losses but revenue climbsLSE:0RN3Takeda Pharmaceutical Co Ltd
2022/04/1916:19Alliance NewsAlliance NewsTakeda's Nuvaxovid vaccine approved for use in JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
2021/09/0714:10Alliance NewsAlliance NewsTakeda inks deal with Japan's government to supply Novavax vaccinesLSE:0RN3Takeda Pharmaceutical Co Ltd
2021/06/1001:22PR Newswire (US)Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient communityLSE:0RN3Takeda Pharmaceutical Co Ltd
2021/06/1001:21PR Newswire (US)Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient communityLSE:0RN3Takeda Pharmaceutical Co Ltd
2021/05/1116:30Alliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical profit surges; guides boosted revenueLSE:0RN3Takeda Pharmaceutical Co Ltd
2020/10/2916:41Alliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical Ups Guidance As Profit Rises In HalfLSE:0RN3Takeda Pharmaceutical Co Ltd
2020/08/0719:25Alliance NewsAlliance NewsNovavax Turns To Takeda To Manufacture Covid-19 Vaccine In JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
2020/08/0319:35Alliance NewsAlliance NewsGLOBAL TRADING UPDATE SUMMARY: Murata's First-Quarter Profit Drops 15%LSE:0RN3Takeda Pharmaceutical Co Ltd
2020/07/3119:04Alliance NewsAlliance NewsTOP NEWS: Takeda Profit More Than Triples In Quarter; Ups GuidanceLSE:0RN3Takeda Pharmaceutical Co Ltd
2020/06/2918:06Alliance NewsAlliance NewsTakeda Earnings To Be Hurt By Novartis Pulling Xiidra ApplicationLSE:0RN3Takeda Pharmaceutical Co Ltd
2020/06/2218:10Alliance NewsAlliance NewsTakeda Pharmaceutical To Get USD564 Million One-Off Profit BoostLSE:0RN3Takeda Pharmaceutical Co Ltd
2020/06/1519:33Alliance NewsAlliance NewsTakeda Pharmaceutical Reports Positive Hemophilia Studies ResultsLSE:0RN3Takeda Pharmaceutical Co Ltd
 검색 관련기사 보기:LSE:0RN3

최근 히스토리

ASX
CXM
Centrex
LSE
AO63
Sigma Fin.frn09
COIN
VINUBTC
Vita Inu
LSE
MDCG
KOSDAQ
052710
아모텍
BOV
PETRL240
PETRL240 Ex:14,13
NASDAQ
DAVE
Dave
USOTC
FITGF
Foxconn Interconnect Tec... (PK)
COIN
TRXCEUR
TronClassic
NYSE
APX
BIT
S30148
Societe Generale Effekten
USOTC
NPPSF
Nippon Sharyo Seizo (PK)
LSE
0Q4E
Slovenske Energeticke St...
BIT
F06718
Vontobel Financial Produ...
KOSPI
570066
True Inverse 2x Vietnam ...
EU
CADDW
Caisse Amort Dette Socia...
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유